ARCHIVES

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014